{"entity":{"type":"insider","cik":"0001833486","url":"/insider/0001833486","json_url":"/insider/0001833486.json","name":"Column Group LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":54,"n_filings":8,"first":"2021-08-24","last":"2022-05-27","span_basis":"filed_date"},"name_variants":[{"name":"Column Group LLC","source":"filing","n_filings":8,"first_seen":"2021-08-24","last_seen":"2022-05-27"}],"transactions":[{"id":6914379,"accession":"0000899243-22-019937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019937","line_url":"/filing/0000899243-22-019937","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Kutzkey Tim; Column Group LLC; Ponoi II Management, LLC; Svennilson Peter; Ponoi Management, LLC; Column Group II GP, LP; COLUMN GROUP II, LP; GOEDDEL DAVID V; PONOI CAPITAL, LP; Ponoi Capital II, LP","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900.0,"shares_display":"1,900","price_per_share":12.4549,"price_display":"12.45","price_state":"stated","total_value":23664.31,"total_display":"23,664.31","total_whole":"23,664","shares_owned_after":1236261.0,"shares_owned_after_display":"1,236,261","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-27","scope":"insider","n_lines":2},{"id":6803762,"accession":"0000899243-22-019470","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-019470","line_url":"/filing/0000899243-22-019470","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Svennilson Peter; Ponoi Capital II, LP; PONOI CAPITAL, LP; GOEDDEL DAVID V; Ponoi Management, LLC; Kutzkey Tim; Column Group LLC; Column Group II GP, LP; COLUMN GROUP II, LP; Ponoi II Management, LLC","owner_display_name":"Svennilson Peter","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16314.0,"shares_display":"16,314","price_per_share":12.0021,"price_display":"12.00","price_state":"stated","total_value":195802.2594,"total_display":"195,802.26","total_whole":"195,802","shares_owned_after":1234424.0,"shares_owned_after_display":"1,234,424","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-25","scope":"insider","n_lines":2},{"id":6803752,"accession":"0000899243-22-019470","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019470","line_url":"/filing/0000899243-22-019470","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Svennilson Peter; Ponoi Capital II, LP; PONOI CAPITAL, LP; GOEDDEL DAVID V; Ponoi Management, LLC; Kutzkey Tim; Column Group LLC; Column Group II GP, LP; COLUMN GROUP II, LP; Ponoi II Management, LLC","owner_display_name":"Svennilson Peter","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10236.0,"shares_display":"10,236","price_per_share":12.4993,"price_display":"12.50","price_state":"stated","total_value":127942.8348,"total_display":"127,942.83","total_whole":"127,943","shares_owned_after":1218648.0,"shares_owned_after_display":"1,218,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider","n_lines":2},{"id":6341626,"accession":"0000899243-22-017787","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-017787","line_url":"/filing/0000899243-22-017787","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Column Group II GP, LP; PONOI CAPITAL, LP; Kutzkey Tim; Column Group LLC; Ponoi Capital II, LP; GOEDDEL DAVID V; Svennilson Peter; Ponoi II Management, LLC; Ponoi Management, LLC; COLUMN GROUP II, LP","owner_display_name":"Column Group II GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250000.0,"shares_display":"1,250,000","price_per_share":10.6715,"price_display":"10.67","price_state":"stated","total_value":13339375.0,"total_display":"13,339,375.00","total_whole":"13,339,375","shares_owned_after":1208750.0,"shares_owned_after_display":"1,208,750","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-12","scope":"insider","n_lines":2},{"id":4205318,"accession":"0000899243-21-038196","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-038196","line_url":"/filing/0000899243-21-038196","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Ponoi Management, LLC; Kutzkey Tim; Column Group LLC; Ponoi Capital II, LP; Svennilson Peter; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Column Group II GP, LP; Ponoi II Management, LLC; GOEDDEL DAVID V","owner_display_name":"Ponoi Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9239.0,"shares_display":"9,239","price_per_share":34.57055796081827,"price_display":"34.57","price_state":"stated","total_value":319397.385,"total_display":"319,397.38","total_whole":"319,397","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-27","filed_date":"2021-09-29","scope":"insider","n_lines":3},{"id":4306616,"accession":"0000899243-21-036293","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000899243-21-036293","line_url":"/filing/0000899243-21-036293","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"GOEDDEL DAVID V; Column Group II GP, LP; Kutzkey Tim; Column Group LLC; Ponoi Management, LLC; Ponoi II Management, LLC; Svennilson Peter; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Capital II, LP","owner_display_name":"GOEDDEL DAVID V","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33535.0,"shares_display":"33,535","price_per_share":37.34660615476368,"price_display":"37.35","price_state":"stated","total_value":1252418.4374,"total_display":"1,252,418.44","total_whole":"1,252,418","shares_owned_after":4720.0,"shares_owned_after_display":"4,720","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-16","scope":"insider","n_lines":4},{"id":4306593,"accession":"0000899243-21-036293","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-21-036293","line_url":"/filing/0000899243-21-036293","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"GOEDDEL DAVID V; Column Group II GP, LP; Kutzkey Tim; Column Group LLC; Ponoi Management, LLC; Ponoi II Management, LLC; Svennilson Peter; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Capital II, LP","owner_display_name":"GOEDDEL DAVID V","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":147676.0,"shares_display":"147,676","price_per_share":36.937617319672796,"price_display":"36.94","price_state":"stated","total_value":5454799.5753,"total_display":"5,454,799.58","total_whole":"5,454,800","shares_owned_after":28466.0,"shares_owned_after_display":"28,466","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-16","scope":"insider","n_lines":9},{"id":4163572,"accession":"0000899243-21-035845","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000899243-21-035845","line_url":"/filing/0000899243-21-035845","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Ponoi II Management, LLC; Kutzkey Tim; Column Group LLC; GOEDDEL DAVID V; Column Group II GP, LP; Ponoi Capital II, LP; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Management, LLC; Svennilson Peter","owner_display_name":"Ponoi II Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14317.0,"shares_display":"14,317","price_per_share":35.268770105469024,"price_display":"35.27","price_state":"stated","total_value":504942.9816,"total_display":"504,942.98","total_whole":"504,943","shares_owned_after":72317.0,"shares_owned_after_display":"72,317","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-14","scope":"insider","n_lines":3},{"id":4163561,"accession":"0000899243-21-035845","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000899243-21-035845","line_url":"/filing/0000899243-21-035845","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Ponoi II Management, LLC; Kutzkey Tim; Column Group LLC; GOEDDEL DAVID V; Column Group II GP, LP; Ponoi Capital II, LP; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Management, LLC; Svennilson Peter","owner_display_name":"Ponoi II Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21738.0,"shares_display":"21,738","price_per_share":35.19214364706965,"price_display":"35.19","price_state":"stated","total_value":765006.8186,"total_display":"765,006.82","total_whole":"765,007","shares_owned_after":76987.0,"shares_owned_after_display":"76,987","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-14","scope":"insider","n_lines":3},{"id":4563785,"accession":"0000899243-21-035109","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-035109","line_url":"/filing/0000899243-21-035109","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Column Group II GP, LP; Ponoi Management, LLC; PONOI CAPITAL, LP; Svennilson Peter; Ponoi Capital II, LP; GOEDDEL DAVID V; COLUMN GROUP II, LP; Ponoi II Management, LLC; Kutzkey Tim; Column Group LLC","owner_display_name":"Column Group II GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37101.0,"shares_display":"37,101","price_per_share":35.431699970351204,"price_display":"35.43","price_state":"stated","total_value":1314551.5006,"total_display":"1,314,551.50","total_whole":"1,314,552","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-03","scope":"insider","n_lines":2},{"id":4563775,"accession":"0000899243-21-035109","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-035109","line_url":"/filing/0000899243-21-035109","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Column Group II GP, LP; Ponoi Management, LLC; PONOI CAPITAL, LP; Svennilson Peter; Ponoi Capital II, LP; GOEDDEL DAVID V; COLUMN GROUP II, LP; Ponoi II Management, LLC; Kutzkey Tim; Column Group LLC","owner_display_name":"Column Group II GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31749.0,"shares_display":"31,749","price_per_share":35.23234481400989,"price_display":"35.23","price_state":"stated","total_value":1118591.7155,"total_display":"1,118,591.72","total_whole":"1,118,592","shares_owned_after":18545.0,"shares_owned_after_display":"18,545","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-03","scope":"insider","n_lines":4},{"id":4662120,"accession":"0000899243-21-034085","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0000899243-21-034085","line_url":"/filing/0000899243-21-034085","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Kutzkey Tim; Column Group LLC; Svennilson Peter; GOEDDEL DAVID V; Column Group II GP, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Management, LLC","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22867.0,"shares_display":"22,867","price_per_share":31.417003529103074,"price_display":"31.42","price_state":"stated","total_value":718412.6197,"total_display":"718,412.62","total_whole":"718,413","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-24","filed_date":"2021-08-24","scope":"insider","n_lines":6},{"id":4662098,"accession":"0000899243-21-034085","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-21-034085","line_url":"/filing/0000899243-21-034085#line-12","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Kutzkey Tim; Column Group LLC; Svennilson Peter; GOEDDEL DAVID V; Column Group II GP, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Management, LLC","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13623.0,"shares_display":"13,623","price_per_share":31.4035,"price_display":"31.40","price_state":"stated","total_value":427809.8805,"total_display":"427,809.88","total_whole":"427,810","shares_owned_after":42095.0,"shares_owned_after_display":"42,095","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-24","scope":"insider"},{"id":4662094,"accession":"0000899243-21-034085","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-21-034085","line_url":"/filing/0000899243-21-034085#line-11","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Kutzkey Tim; Column Group LLC; Svennilson Peter; GOEDDEL DAVID V; Column Group II GP, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Management, LLC","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12969.0,"shares_display":"12,969","price_per_share":31.4113,"price_display":"31.41","price_state":"stated","total_value":407373.1497,"total_display":"407,373.15","total_whole":"407,373","shares_owned_after":42411.0,"shares_owned_after_display":"42,411","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-24","scope":"insider"},{"id":4662091,"accession":"0000899243-21-034085","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000899243-21-034085","line_url":"/filing/0000899243-21-034085#line-10","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Kutzkey Tim; Column Group LLC; Svennilson Peter; GOEDDEL DAVID V; Column Group II GP, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Management, LLC","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12354.0,"shares_display":"12,354","price_per_share":31.4168,"price_display":"31.42","price_state":"stated","total_value":388123.1472,"total_display":"388,123.15","total_whole":"388,123","shares_owned_after":13518.0,"shares_owned_after_display":"13,518","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-24","scope":"insider"},{"id":4662087,"accession":"0000899243-21-034085","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-21-034085","line_url":"/filing/0000899243-21-034085#line-9","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Kutzkey Tim; Column Group LLC; Svennilson Peter; GOEDDEL DAVID V; Column Group II GP, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Management, LLC","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8204.0,"shares_display":"8,204","price_per_share":30.9429,"price_display":"30.94","price_state":"stated","total_value":253855.5516,"total_display":"253,855.55","total_whole":"253,856","shares_owned_after":25872.0,"shares_owned_after_display":"25,872","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-24","scope":"insider"},{"id":4662084,"accession":"0000899243-21-034085","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-21-034085","line_url":"/filing/0000899243-21-034085#line-8","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Kutzkey Tim; Column Group LLC; Svennilson Peter; GOEDDEL DAVID V; Column Group II GP, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Management, LLC","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7605.0,"shares_display":"7,605","price_per_share":30.9267,"price_display":"30.93","price_state":"stated","total_value":235197.5535,"total_display":"235,197.55","total_whole":"235,198","shares_owned_after":55380.0,"shares_owned_after_display":"55,380","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-24","scope":"insider"},{"id":4662080,"accession":"0000899243-21-034085","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-21-034085","line_url":"/filing/0000899243-21-034085#line-7","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Kutzkey Tim; Column Group LLC; Svennilson Peter; GOEDDEL DAVID V; Column Group II GP, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Management, LLC","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7278.0,"shares_display":"7,278","price_per_share":30.9187,"price_display":"30.92","price_state":"stated","total_value":225026.2986,"total_display":"225,026.30","total_whole":"225,026","shares_owned_after":55718.0,"shares_owned_after_display":"55,718","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-24","scope":"insider"},{"id":4662077,"accession":"0000899243-21-034085","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-034085","line_url":"/filing/0000899243-21-034085#line-6","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Kutzkey Tim; Column Group LLC; Svennilson Peter; GOEDDEL DAVID V; Column Group II GP, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Management, LLC","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":32.349,"price_display":"32.35","price_state":"stated","total_value":71167.8,"total_display":"71,167.80","total_whole":"71,168","shares_owned_after":40211.0,"shares_owned_after_display":"40,211","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-24","scope":"insider"},{"id":4662074,"accession":"0000899243-21-034085","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-21-034085","line_url":"/filing/0000899243-21-034085#line-5","is_derivative":false,"issuer_cik":"0001182464","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001182464","owner_cik":null,"owner_name":"Kutzkey Tim; Column Group LLC; Svennilson Peter; GOEDDEL DAVID V; Column Group II GP, LP; Ponoi Capital II, LP; Ponoi II Management, LLC; COLUMN GROUP II, LP; PONOI CAPITAL, LP; Ponoi Management, LLC","owner_display_name":"Kutzkey Tim","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":32.3831,"price_display":"32.38","price_state":"stated","total_value":68004.51,"total_display":"68,004.51","total_whole":"68,005","shares_owned_after":11418.0,"shares_owned_after_display":"11,418","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-24","scope":"insider"}],"collapsed":true,"next_cursor":"2021-08-23|4662074","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001673772","name":"RAPT Therapeutics, Inc.","url":"/issuer/0001673772","role":"Ten percent owner","n_filings":8,"first_seen":"2021-08-24","last_seen":"2022-05-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001833486","retrieved_at":"2026-08-26T03:25:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}